Figure 4
The prevalence of resistance associated variants in various genotypes (GTs). Frequency of all RAVs for different DAAs (A) and regions (B). Frequency of clinically relevant RAVs for different DAAs (C) and regions (D).
Figure 4 | Scientific Reports
